抗CV2/CRMP5自身免疫性疼痛的机制和治疗方法
Laurent Martin1,2, Harrison J Stratton1, Kimberly Gomez1
1Department of Pharmacology, College of Medicine, The University of Arizona, Tucson, AZ, 85724 USA.
bioRxiv : the preprint server for biology
|May 20, 2024
概括
在癌症患者中,对CV2 /ollapsin响应媒介蛋白5 (CRMP5) 抗原的自身免疫反应会导致疼痛的神经病变. 这项研究揭示了CV2 / CRMP5自身抗体直接增加感官神经元刺激性,导致疼痛.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 麻性神经综合征 (PNS) 与癌症患者对神经系统抗原的自身免疫反应有关.
- 患有小细胞肺癌或胸腺瘤的患者可能会对CV2 /ollapsin响应媒介蛋白5 (CRMP5) 抗原产生自身抗体.
- 一个显著的多数 (大约. 80%的这些患者患有疼痛性神经病变,其潜在机制尚不清楚.
研究的目的:
- 研究抗CV2/CRMP5自身抗体 (CV2/CRMP5-Abs) 诱导神经瘤神经综合征的疼痛的机制.
- 阐明CV2/CRMP5-Abs对神经元功能和疼痛通路的直接影响.
主要方法:
- 来自患者的CV2 / CRMP5-Abs被测试为结合动物背部根 (DRG) 和脊髓.
- 在大鼠中评估了CV2/CRMP5-Abs对DRG神经元刺激性和机械过敏性的影响.
- 用大鼠的遗传免疫来模拟CV2/CRMP5-Abs. 的影响.
主要成果:
- 来自患者的CV2/CRMP5-Abs在动物的DRG和脊髓中与CRMP5结合.
- 在大鼠中,CV2/CRMP5-Abs诱导了DRG神经元过敏和机械过敏,通过阻断CRMP5结合而消除了这些影响.
- 在老鼠中观察到的效应模仿了患者的症状,验证了模型.
结论:
- CV2/CRMP5-Abs通过增加感官神经元刺激性,直接导致神经病变性神经综合征中的神经病痛.
- 这项研究揭示了自抗体诱导疼痛的新型神经元机制.
- 针对CV2/CRMP5-Abs的治疗策略,例如B淋巴细胞枯竭,显示出治疗PNS疼痛的希望.
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Analgesia and Pain Management
582
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
582
Autoimmune Disorders
417
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
417
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
131
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
131


